Ultra Zx Labs is recalling UltraZx weight loss supplements because it contains undeclared Sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in 2010 because it substantially increases blood pressure and can be a “significant risk” for patients with a history of heart disease or stroke. Phenolphthalein is not approved as a supplement or a drug because it causes cancer.
No reports of adverse events have been received to date. UltraZx weight loss supplement is marketed as a dietary supplement and is packaged in bottles of 30 capsules of 300 mg each. This recall includes all lots/bottles/packages. They were sold from September 2014 until February 2015.
Do not take this supplement. If you have purchased it, return to the place of purchase for a refund. If you have experienced an adverse reaction after taking this product, report it to the FDA’s MedWatch Adverse Event Reporting program.
